Stevens Capital Management’s CONMED CNMD Stock Holding History

Stevens Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,325	Closed	-$373K	–	772
2017 Q4	$373K	Buy	7,325 +118	+2%	+$6.15K	0.01%	612
2017 Q3	$378K	Sell	7,207 -6,321	-47%	-$317K	0.01%	619
2017 Q2	$689K	Buy	+13,528	New	+$669K	0.03%	509
2015 Q4	–	Sell	-6,162	Closed	-$294K	–	951
2015 Q3	$294K	Buy	+6,162	New	+$338K	0.01%	706
2015 Q2	–	Sell	-4,407	Closed	-$223K	–	1049
2015 Q1	$223K	Sell	4,407 -2,408	-35%	-$118K	0.01%	825
2014 Q4	$306K	Sell	6,815 -672	-9%	-$28.2K	0.01%	709
2014 Q3	$276K	Sell	7,487 -5,204	-41%	-$206K	0.01%	763
2014 Q2	$560K	Buy	12,691 +1,302	+11%	+$59K	0.02%	635
2014 Q1	$495K	Buy	+11,389	New	+$508K	0.01%	664
2013 Q3	–	Sell	-11,016	Closed	-$344K	–	1051
2013 Q2	$344K	Buy	+11,016	New	+$357K	0.01%	674

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Stevens Capital Management's CNMD Position: Q1 2018 in Review

Stevens Capital Management sold out of CONMED (CNMD) in Q1 2018, closing a stake of 7,325 shares — an estimated $373K sold.

Stevens Capital Management first reported a position in CNMD in Q2 2013 and held it in 10 quarters. The position peaked at $689K in Q2 2017. 173 funds tracked by Wall St. Rank hold CNMD as of Q1 2018.

Stevens Capital Management reported no remaining CONMED position as of Q1 2018 after selling out during the quarter.
Stevens Capital Management sold 7,325 CONMED shares in Q1 2018, an estimated $373K.
Stevens Capital Management first reported a position in CONMED in Q2 2013 and held it in 10 quarters.
Stevens Capital Management's CONMED position peaked at $689K in Q2 2017.
173 funds tracked by Wall St. Rank held CONMED as of Q1 2018.

Based on Stevens Capital Management's 13F filing for Q1 2018, filed 8 May 2018.